Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
GIMAP6 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
GPR20 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ANPEP - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
GAPDHP62 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC100506189 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
TUBA3D - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ALDH7A1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ANAPC16 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101929019 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
RBM3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ENSA - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GRAP2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NPAS3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
C1GALT1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LCK - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DDX59 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on